8%), although the difference did not reach statistical significance, likely due to the small sample size.
← all excerpts
Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study.
1
—
—